Iron-overload-related disease in HFE hereditary hemochromatosis

New England Journal of Medicine

Volumn 358, Issue 3, 2008, Pages 221-230

  Allen, Katrina J ^a,i   Gurrin, Lyle C ^a   Constantine, Clare C ^a   Osborne, Nicholas J ^a   Delatycki, Martin B ^a   Nicoll, Amanda J ^b   McLaren, Christine E ^g   Bahlo, Melanie ^c   Nisselle, Amy E ^a   Vulpe, Chris D ^h   Anderson, Gregory J ^d   Southey, Melissa C ^a   Giles, Graham G ^a,e   English, Dallas R ^a,e   Hopper, John L ^a   Olynyk, John K ^f   Powell, Lawrie W ^d   Gertig, Dorota M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e CANCER EPIDEMIOLOGY CENTRE   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HFE PROTEIN;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTHROPATHY; ARTICLE; FATIGUE; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC RISK; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 38349079861     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa073286     Document Type: Article

References (26)

1. Pietrangelo A. Hereditary hemochromatosis. Annu Rev Nutr 2006;26:251-70.
2. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993;328:1616-20.
3. Falize L, Guillygomarc'h A, Perrin M, et al. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology 2006;44:472-7.
4. Powell LW, Dixon JL, Ramm GA, et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med 2006;166:294-301.
5. Guyader D, Jacquelinet C, Moirand R, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929-36.
6. Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
7. Adams PC, Barton JC. Haemochromatosis. Lancet 2007;370:1855-60.
8. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004;350:2383-97.
9. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-78.
10. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
11. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24.
12. Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general population: iron overload progression rate. Blood 2004;103:2914-9.
13. Delatycki MB, Allen KJ, Nisselle AE, et al. Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. Lancet 2005;366:314-6.
14. Whitlock EP, Garlitz BA, Harris EL, Beil TL, Smith PR. Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2006;145:209-23.
15. Tavill AS. Diagnosis and management of hemochromatosis. Hepatology 2001;33:1321-8.
16. Adams P, Brissot P, Powell LW. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000;33:485-504.
17. Bulaj ZJ, Ajioka RS, Phillips JD, et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 2000;343:1529-35.
18. Giles GG, English DR. The Melbourne Collaborative Cohort Study. In: Riboli E, Lambert R, eds. Nutrition and lifestyle: opportunities for cancer prevention. Lyon, France: International Agency for Research on Cancer, 2002:69-70. (IARC scientific publications no. 156.)
19. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002;122:646-51. [Erratum, Gastroenterology 2002; 122:1191.]
20. Worwood M. Inherited iron loading: genetic testing in diagnosis and management. Blood Rev 2005;19:69-88.
21. Olynyk JK, Hagan SE, Cullen DJ, Beilby J, Whittall DE. Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study. Mayo Clin Proc 2004;79:309-13.
22. Allen KJ, Warner B, Delatycki MB. Clinical haemochromatosis in HFE mutation carriers. Lancet 2002;360:412-3.
23. Ajioka RS, Kushner JP. Clinical consequences of iron overload in hemochromatosis homozygotes. Blood 2003;101:3351-3.
24. Barton JC, Wiener HW, Acton RT, Go RC. HLA haplotype A*03- B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Blood Cells Mol Dis 2005;34:38-47.
25. Beutler E, Barton JC, Felitti VJ, et al. Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis 2003;31:305-9.
26. Rivers CA, Barton JC, Gordeuk VR, et al. Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells Mol Dis 2007;38:247-52.